Evaluating the safety of angiotensin pathway drugs in COVID-19.
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: C19-IUC-212
Grant search
Key facts
Disease
COVID-19Funder
UK Research and Innovation (UKRI)Principal Investigator
PendingResearch Location
United KingdomLead Research Institution
MRC Centre for Drug Safety Science at the University of LiverpoolResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
6y
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Safety of angiotensin pathway drugs in COVID-19